About this document
Atranorin From Lichens Act As Potential Inhibitor For Cervical Tumor Proteins by Vinutha Asundi is a document available to read on EtoBox.
The study identifies and isolates atranorin, a potential anticancer compound from the lichen Heterodermia boryi, and evaluates its pharmacological effects against cervical cancer. Atranorin exhibits significant in vitro and in vivo anticancer activity, reducing tumor growth and weight, and shows a stronger binding affinity to cervical cancer target proteins compared to standard drugs. The findings suggest that atranorin could serve as a promising drug candidate for cervical cancer treatment, pending further
- Author
- Vinutha Asundi
- Language
- EN